271 related articles for article (PubMed ID: 32532530)
1. The utility of intraoperative contrast-enhanced ultrasound in detecting residual disease after focal HIFU for localized prostate cancer.
Bacchetta F; Martins M; Regusci S; Jichlinski P; Meuwly JY; Lucca I; Valerio M
Urol Oncol; 2020 Nov; 38(11):846.e1-846.e7. PubMed ID: 32532530
[TBL] [Abstract][Full Text] [Related]
2. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of post-ablation mpMRI as a predictor of residual prostate cancer after focal high intensity focused ultrasound (HIFU) ablation.
Khandwala YS; Morisetty S; Ghanouni P; Fan RE; Soerensen SJC; Rusu M; Sonn GA
Urol Oncol; 2022 Nov; 40(11):489.e9-489.e17. PubMed ID: 36058811
[TBL] [Abstract][Full Text] [Related]
4. Follow-up after focal therapy of the prostate with high intensity focused ultrasound (HIFU) using contrast enhanced ultrasound (CEUS) in combination with MRI image fusion.
Apfelbeck M; Chaloupka M; Schlenker B; Stief CG; Clevert DA
Clin Hemorheol Microcirc; 2019; 73(1):135-143. PubMed ID: 31561350
[TBL] [Abstract][Full Text] [Related]
5. Oncological Outcome and Value of Postoperative Magnetic Resonance Imaging after Focal High-Intensity Focused Ultrasound Therapy for Prostate Cancer.
Rosenhammer B; Niessen C; Rotzinger L; Reiss J; Schnabel MJ; Burger M; Bründl J
Urol Int; 2019; 103(3):270-278. PubMed ID: 31466073
[TBL] [Abstract][Full Text] [Related]
6. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prostate Cancer.
Khandwala YS; Soerensen SJC; Morisetty S; Ghanouni P; Fan RE; Vesal S; Rusu M; Sonn GA
Eur Urol Focus; 2023 Jul; 9(4):584-591. PubMed ID: 36372735
[TBL] [Abstract][Full Text] [Related]
7. Role of Systematic Control Biopsies following Partial Gland Ablation with High-Intensity Focused Ultrasound for Clinically Significant Prostate Cancer.
Rompré-Brodeur A; Marcq G; Tholomier C; Fugaru I; Loutochin O; Anidjar M; Bladou F
J Urol; 2021 Nov; 206(5):1177-1183. PubMed ID: 34251879
[TBL] [Abstract][Full Text] [Related]
8. Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation.
Felker ER; Raman SS; Lu DSK; Tuttle M; Margolis DJ; ElKhoury FF; Sayre J; Marks LS
AJR Am J Roentgenol; 2019 Dec; 213(6):1253-1258. PubMed ID: 31361529
[No Abstract] [Full Text] [Related]
9. MRI-based monitoring of prostate cancer after HIFU: Inter-reader agreement and diagnostic performance of the PI-FAB score.
Pausch AM; Elsner C; Rupp NJ; Eberli D; Hötker AM
Eur J Radiol; 2024 Jun; 175():111463. PubMed ID: 38615502
[TBL] [Abstract][Full Text] [Related]
10. Does mpMRI guidance improve HIFU partial gland ablation compared to conventional ultrasound guidance? Early functional outcomes and complications from a single center.
Sivaraman A; Marra G; Stabile A; Mombet A; Macek P; Lanz C; Cathala N; Moschini M; Carneiro A; Sanchez-Salas R; Cathelineau X
Int Braz J Urol; 2020; 46(6):984-992. PubMed ID: 32822127
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancer.
Dickinson L; Ahmed HU; Hindley RG; McCartan N; Freeman A; Allen C; Emberton M; Kirkham AP
Urol Oncol; 2017 Jan; 35(1):30.e9-30.e15. PubMed ID: 27663393
[TBL] [Abstract][Full Text] [Related]
12. Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer?
Rakauskas A; Shah TT; Peters M; Randeva JS; Hosking-Jervis F; Schmainda MJ; Orczyck C; Emberton M; Arya M; Moore C; Ahmed HU
Urol Oncol; 2021 Dec; 39(12):830.e1-830.e8. PubMed ID: 34049783
[TBL] [Abstract][Full Text] [Related]
13. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy.
van den Bos W; de Bruin DM; van Randen A; Engelbrecht MR; Postema AW; Muller BG; Varkarakis IM; Skolarikos A; Savci-Heijink CD; Jurhill RR; Zondervan PJ; Laguna Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ
Eur Radiol; 2016 Jul; 26(7):2252-60. PubMed ID: 26449559
[TBL] [Abstract][Full Text] [Related]
14. An Exploratory Study of Dose Escalation
Huber PM; Afzal N; Arya M; Boxler S; Dudderidge T; Emberton M; Guillaumier S; Hindley RG; Hosking-Jervis F; Leemann L; Lewi H; McCartan N; Moore CM; Nigam R; Odgen C; Persad R; Thalmann GN; Virdi J; Winkler M; Ahmed HU
J Endourol; 2020 Jun; 34(6):641-646. PubMed ID: 32253928
[No Abstract] [Full Text] [Related]
15.
Burger IA; Müller J; Donati OF; Ferraro DA; Messerli M; Kranzbühler B; Ter Voert EEGW; Muehlematter UJ; Rupp NJ; Mortezavi A; Eberli D
J Nucl Med; 2019 Aug; 60(8):1118-1123. PubMed ID: 30683764
[TBL] [Abstract][Full Text] [Related]
16. Non-Whole-Gland High-Intensity Focused Ultrasound vs Whole-Gland High-Intensity Focused Ultrasound for Management of Localized Prostate Cancer: 1-Year Oncological and Functional Outcomes.
Lei Y; Zanker P; Yildiz S; Hancke K; Seidl D; Koch O; Schwentner C; Mundhenk J
J Endourol; 2019 Feb; 33(2):100-106. PubMed ID: 30526029
[TBL] [Abstract][Full Text] [Related]
17. [HIFU therapy of localized prostate cancer using image-guided robotic HIFU Focal One].
Govorov AV; Vasilyev AO; Alaverdyan AI; Kolontarev KB; Pushkar DY
Urologiia; 2023 May; (2):83-89. PubMed ID: 37401710
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: A prospective development study.
Valerio M; Shah TT; Shah P; Mccartan N; Emberton M; Arya M; Ahmed HU
Urol Oncol; 2017 Apr; 35(4):150.e1-150.e7. PubMed ID: 27955940
[TBL] [Abstract][Full Text] [Related]
19. Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation.
Scheltema MJ; Chang JI; van den Bos W; Böhm M; Delprado W; Gielchinsky I; de Reijke TM; de la Rosette JJ; Siriwardana AR; Shnier R; Stricker PD
Eur Urol Focus; 2019 Jul; 5(4):585-591. PubMed ID: 29102671
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
